vs
Side-by-side financial comparison of Life360, Inc. (LIF) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $146.0M, roughly 1.1× Life360, Inc.). Life360, Inc. runs the higher net margin — 88.8% vs -82.0%, a 170.8% gap on every dollar of revenue. On growth, Life360, Inc. posted the faster year-over-year revenue change (26.4% vs -22.7%). Life360, Inc. produced more free cash flow last quarter ($36.6M vs $-36.6M). Over the past eight quarters, Life360, Inc.'s revenue compounded faster (36.6% CAGR vs -11.5%).
Life360, Inc. develops family-focused safety and connectivity platforms. Core offerings include real-time location sharing, emergency alerts, driving behavior analysis tools and identity theft protection. It serves consumer markets across North America, Europe and Asia-Pacific, with most revenue from tiered premium subscription plans.
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
LIF vs PTCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $146.0M | $164.7M |
| Net Profit | $129.7M | $-135.0M |
| Gross Margin | 75.1% | — |
| Operating Margin | 6.1% | -43.3% |
| Net Margin | 88.8% | -82.0% |
| Revenue YoY | 26.4% | -22.7% |
| Net Profit YoY | 1425.9% | -104.8% |
| EPS (diluted) | $1.53 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $146.0M | $164.7M | ||
| Q3 25 | $124.5M | $211.0M | ||
| Q2 25 | $115.4M | $178.9M | ||
| Q1 25 | $103.6M | $1.2B | ||
| Q4 24 | $115.5M | $213.2M | ||
| Q3 24 | $92.9M | $196.8M | ||
| Q2 24 | $84.9M | $186.7M | ||
| Q1 24 | $78.2M | $210.1M |
| Q4 25 | $129.7M | $-135.0M | ||
| Q3 25 | $9.8M | $15.9M | ||
| Q2 25 | $7.0M | $-64.8M | ||
| Q1 25 | $4.4M | $866.6M | ||
| Q4 24 | $8.5M | $-65.9M | ||
| Q3 24 | $7.7M | $-106.7M | ||
| Q2 24 | $-11.0M | $-99.2M | ||
| Q1 24 | $-9.8M | $-91.6M |
| Q4 25 | 75.1% | — | ||
| Q3 25 | 78.0% | — | ||
| Q2 25 | 78.4% | — | ||
| Q1 25 | 80.6% | — | ||
| Q4 24 | 74.0% | — | ||
| Q3 24 | 75.4% | — | ||
| Q2 24 | 75.0% | — | ||
| Q1 24 | 76.7% | — |
| Q4 25 | 6.1% | -43.3% | ||
| Q3 25 | 4.6% | 1.4% | ||
| Q2 25 | 1.7% | -19.5% | ||
| Q1 25 | 2.1% | 82.5% | ||
| Q4 24 | 4.9% | -76.2% | ||
| Q3 24 | -5.3% | -27.7% | ||
| Q2 24 | -2.8% | -21.5% | ||
| Q1 24 | -8.2% | -21.6% |
| Q4 25 | 88.8% | -82.0% | ||
| Q3 25 | 7.9% | 7.5% | ||
| Q2 25 | 6.1% | -36.3% | ||
| Q1 25 | 4.2% | 73.7% | ||
| Q4 24 | 7.4% | -30.9% | ||
| Q3 24 | 8.3% | -54.2% | ||
| Q2 24 | -12.9% | -53.1% | ||
| Q1 24 | -12.5% | -43.6% |
| Q4 25 | $1.53 | $-1.63 | ||
| Q3 25 | $0.11 | $0.20 | ||
| Q2 25 | $0.08 | $-0.83 | ||
| Q1 25 | $0.05 | $10.04 | ||
| Q4 24 | $0.14 | $-0.85 | ||
| Q3 24 | $0.09 | $-1.39 | ||
| Q2 24 | $-0.15 | $-1.29 | ||
| Q1 24 | $-0.14 | $-1.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $494.3M | $1.9B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $548.2M | $-205.3M |
| Total Assets | $959.7M | $2.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $494.3M | $1.9B | ||
| Q3 25 | $455.7M | $1.7B | ||
| Q2 25 | $432.7M | $2.0B | ||
| Q1 25 | $168.9M | $2.0B | ||
| Q4 24 | $159.2M | $1.1B | ||
| Q3 24 | $159.0M | $1.0B | ||
| Q2 24 | $160.8M | $1.1B | ||
| Q1 24 | $73.4M | $884.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $5.2M | — |
| Q4 25 | $548.2M | $-205.3M | ||
| Q3 25 | $391.4M | $-155.8M | ||
| Q2 25 | $366.7M | $-206.5M | ||
| Q1 25 | $376.3M | $-185.8M | ||
| Q4 24 | $358.5M | $-1.1B | ||
| Q3 24 | $339.7M | $-1.1B | ||
| Q2 24 | $326.7M | $-980.2M | ||
| Q1 24 | $239.8M | $-893.9M |
| Q4 25 | $959.7M | $2.9B | ||
| Q3 25 | $787.5M | $2.6B | ||
| Q2 25 | $753.6M | $2.6B | ||
| Q1 25 | $455.4M | $2.7B | ||
| Q4 24 | $441.6M | $1.7B | ||
| Q3 24 | $427.4M | $1.8B | ||
| Q2 24 | $405.9M | $1.9B | ||
| Q1 24 | $318.8M | $1.8B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.02× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $36.8M | $-34.3M |
| Free Cash FlowOCF − Capex | $36.6M | $-36.6M |
| FCF MarginFCF / Revenue | 25.1% | -22.3% |
| Capex IntensityCapex / Revenue | 0.2% | 1.4% |
| Cash ConversionOCF / Net Profit | 0.28× | — |
| TTM Free Cash FlowTrailing 4 quarters | $86.8M | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $36.8M | $-34.3M | ||
| Q3 25 | $26.4M | $-66.3M | ||
| Q2 25 | $13.3M | $-58.3M | ||
| Q1 25 | $12.1M | $870.1M | ||
| Q4 24 | $12.3M | $-30.0M | ||
| Q3 24 | $6.3M | $-77.0M | ||
| Q2 24 | $3.3M | $-71.5M | ||
| Q1 24 | $10.7M | $70.8M |
| Q4 25 | $36.6M | $-36.6M | ||
| Q3 25 | $25.6M | $-69.7M | ||
| Q2 25 | $12.7M | $-59.6M | ||
| Q1 25 | $11.9M | $868.4M | ||
| Q4 24 | $11.2M | $-33.8M | ||
| Q3 24 | $6.3M | $-77.5M | ||
| Q2 24 | $3.2M | $-78.8M | ||
| Q1 24 | — | $61.2M |
| Q4 25 | 25.1% | -22.3% | ||
| Q3 25 | 20.6% | -33.1% | ||
| Q2 25 | 11.0% | -33.3% | ||
| Q1 25 | 11.5% | 73.8% | ||
| Q4 24 | 9.7% | -15.8% | ||
| Q3 24 | 6.8% | -39.4% | ||
| Q2 24 | 3.8% | -42.2% | ||
| Q1 24 | — | 29.1% |
| Q4 25 | 0.2% | 1.4% | ||
| Q3 25 | 0.6% | 1.6% | ||
| Q2 25 | 0.6% | 0.7% | ||
| Q1 25 | 0.1% | 0.1% | ||
| Q4 24 | 1.0% | 1.8% | ||
| Q3 24 | 0.0% | 0.3% | ||
| Q2 24 | 0.1% | 4.0% | ||
| Q1 24 | 0.0% | 4.6% |
| Q4 25 | 0.28× | — | ||
| Q3 25 | 2.70× | -4.17× | ||
| Q2 25 | 1.90× | — | ||
| Q1 25 | 2.75× | 1.00× | ||
| Q4 24 | 1.45× | — | ||
| Q3 24 | 0.83× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
